Blog

How Do You Raise Your First VC Round or Set Your Startup Valuation? These Philly Investors Have Some Advice

May 17, 2022

If you’re a first-time founder looking to raise an institutional round of venture capital for the first time, how do you know where to start? How does one know how much to raise or where their valuation lies? It’s a position many startup founders will find themselves in within their first few years. It’s also […]

Caterpillar Acquires Tangent Energy Solutions

May 11, 2022

Caterpillar Inc. (NYSE: CAT) has acquired Tangent Energy Solutions, a U.S.-based energy-as-a-service (EaaS) company. Headquartered in Kennett Square, Pennsylvania, Tangent Energy provides customers with turnkey solutions for reducing energy costs, increasing energy efficiency, reducing emissions, monetizing electric grid support and providing resiliency for customer operations. “Tangent Energy has developed a suite of intelligent energy solutions […]

Why Houwzer Launched This Nonprofit Fund for Low-Income, First-Time Homebuyers

April 28, 2022

Tech-enabled real estate brokerage Houwzer this week launched the RiseUp Fund, a nonprofit to bring grants and resources to low- to moderate-income first-time homebuyers. The Center City company’s new program comes amid a still-hot housing market and the recent re-up of the Philadelphia Housing Development Corp.’s own $10,000 grant program for first-time homebuyers, Philly First […]

How Oncora Medical’s CEO Realized its Product Could Help with Healthcare Burnout

April 15, 2022

It’s not solving a new problem, but Oncora Medical’s CEO is finding that the company’s product has an unfortunate timeliness amid the pandemic. The seven-year-old digital health company, which makes a software that provides documentation, workflow and data-capturing for cancer doctors, added two big names to its client list this week. Cancer centers Scripps Health […]

PolyCore Therapeutics Secures Seed Financing to Address Motor Symptoms and Dyskinesia Associated with Parkinson’s Disease

April 12, 2022

PolyCore Therapeutics, Inc., a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders, today announced a seed investment from Xontogeny, LLC and Ben Franklin Technology Partners of Southeastern Pennsylvania to advance their lead compound, PCT-3012, a novel G protein-biased D3 receptor agonist to reduce motor impairment in Parkinson’s […]